Aurora Cannabis (ACB) Interest Expenses (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Interest Expenses of $1.3 million for Q1 2026, up 288.9% year-on-year from $339192.8 in Q1 2025, and up 288.9% on a QoQ basis from -$698310.3 in Q1 2025.
Aurora Cannabis (ACB) Interest Expenses (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Interest Expenses for 10 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.
- Quarterly Interest Expenses rose 288.9% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 42.73% YoY) and the FY2026 annual result came in at $3.4 million, down 3.51% from the prior year.
- Interest Expenses advanced to $1.3 million in Q1 2026 per ACB's latest filing, from -$698310.3 in the prior quarter.
- Over the last five years, Interest Expenses for ACB reached as high as $21.8 million in Q1 2023 and fell as low as -$698310.3 in Q1 2025.
- A 5-year average of $4.6 million and a median of $1.5 million in 2024 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses sank 37.09% — and 2023, when it surged 1028.12%.
- Year by year, Interest Expenses stood at $8.2 million in 2022, then jumped by 167.26% to $21.8 million in 2023, then slumped by 93.53% to $1.4 million in 2024, then plunged by 149.37% to -$698310.3 in 2025, then jumped by 288.9% to $1.3 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $1.3 million, -$698310.3, and $1.4 million for Q1 2026, Q1 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.77 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 1.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.32 Mn |
| Mar 31, 2026 | 1.32 Mn |
| Mar 31, 2025 | -698,310.31 |
| Mar 31, 2025 | -698,310.31 |
| Dec 31, 2024 | 1.41 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Sep 30, 2024 | 1.59 Mn |
| Sep 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.29 Mn |
| Mar 31, 2023 | 21.85 Mn |
| Mar 31, 2023 | 21.85 Mn |
| Jun 30, 2022 | 8.17 Mn |
| Jun 30, 2022 | 8.17 Mn |
| Mar 31, 2022 | 1.94 Mn |
| Mar 31, 2022 | 1.94 Mn |
| Dec 31, 2021 | 11.35 Mn |
| Dec 31, 2021 | 11.35 Mn |
| Sep 30, 2021 | 12.19 Mn |
| Sep 30, 2021 | 12.19 Mn |